MEIRAGTX LIMITED
MEIRAGTX LIMITED is a private limited company registered in the United Kingdom, under 09501998, incorporated on 20 March 2015. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 11 years. Registered office address: N1 7NQ London, the United Kingdom. Formerly known as KADMON GENE THERAPY HOLDINGS LIMITED. Directors include ALEXANDRIA JOSEFINA FORBES and MR. RICHARD BRIAN GIROUX. Sole shareholder is MEIRAGTX HOLDINGS. Associated with 6 related entities, including MEIRAGTX OCULAR UK LIMITED, MEIRAGTX GENE REGULATION LIMITED, and MEIRAGTX NEURO UK LIMITED. The overall risk score is 0/100 (negligible). No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
KADMON GENE THERAPY HOLDINGS LIMITED
KADMON GENE THERAPY LIMITED
Registered Address
92 BRITANNIA WALK
N1 7NQ LONDON
the United Kingdom
Entity Risk Evaluation
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Companies
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (2)
| Date | Change | Details |
|---|---|---|
| 2026-04-30 | DIRECTOR ADDED | Richard Brian Giroux (director) |
| 2026-04-30 | DIRECTOR ADDED | Alexandria Josefina Forbes (director) |
Source Records (1)
| companieshouse | 09501998 | 2026-06-01 | open_in_new |